colforsin has been researched along with lovastatin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ | 1 |
| Ecay, TW; Valentich, JD | 1 |
| Chiloeches, A; García, N; Lasa, M; Montes, A; Toro, MJ | 1 |
| Gray-Bablin, J; Herliczek, TW; Keyomarsi, K; Rao, S | 1 |
| Beinfeld, MC; Vishnuvardhan, D | 1 |
| Black, SA; Trackman, PC | 1 |
6 other study(ies) available for colforsin and lovastatin
| Article | Year |
|---|---|
Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.
Topics: 3T3 Cells; Adrenergic Uptake Inhibitors; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport, Active; Cell Line; Cell Separation; Cell Survival; Flow Cytometry; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Mice; Protein Binding; Reserpine; Spectrometry, Fluorescence; Substrate Specificity; Time Factors | 2001 |
Lovastatin inhibits cAMP- and calcium-stimulated chloride secretion by T84 cells.
Topics: Calcium; Cell Line; Chlorides; Cholesterol; Colforsin; Colon; Cyclic AMP; Electric Conductivity; Electrophysiology; Glycosylation; Lovastatin; Proteins; Second Messenger Systems | 1993 |
Lovastatin decreases prolactin and growth hormone gene expression in GH4C1 cells through a cAMP dependent mechanism.
Topics: Animals; Anticholesteremic Agents; Cell Line; Chloramphenicol O-Acetyltransferase; Colforsin; Cyclic AMP; Gene Expression; Genes, Reporter; Growth Hormone; GTP-Binding Proteins; Kinetics; Lovastatin; Mevalonic Acid; Pituitary Gland; Prolactin; Promoter Regions, Genetic; Rats; Signal Transduction | 1997 |
The biphasic induction of p21 and p27 in breast cancer cells by modulators of cAMP is posttranscriptionally regulated and independent of the PKA pathway.
Topics: 1-Methyl-3-isobutylxanthine; Breast Neoplasms; Cell Cycle Proteins; Cholera Toxin; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Female; Humans; Isoquinolines; Kinetics; Lovastatin; Microtubule-Associated Proteins; Protein Processing, Post-Translational; Sulfonamides; Transfection; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1999 |
Lovastatin is a potent inhibitor of cholecystokinin secretion in endocrine tumor cells in culture.
Topics: Animals; Colforsin; Endocrine Gland Neoplasms; Lovastatin; Mevalonic Acid; Mice; Rats; Sincalide; Tumor Cells, Cultured | 2000 |
Transforming growth factor-beta1 (TGFbeta1) stimulates connective tissue growth factor (CCN2/CTGF) expression in human gingival fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent mechanism: statins with forskolin block TGFbeta1-induced CCN2/CTGF
Topics: cdc42 GTP-Binding Protein; Cell Nucleus; Colforsin; Connective Tissue Growth Factor; Enzyme Inhibitors; Fibroblasts; Gene Expression Regulation; Genes, Dominant; Gingiva; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Lovastatin; rac1 GTP-Binding Protein; rhoA GTP-Binding Protein; Transforming Growth Factor beta1 | 2008 |